Bank Of New York Mellon Corp Angion Biomedica Corp. Transaction History

Bank Of New York Mellon Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.1 - $2.23 $47,401 - $96,095	-43,092 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$2.35 - $9.95 $2,831 - $11,989	1,205 Added 2.88%	43,092 $125,000
Q3 2021 Nov 12, 2021	BUY	$9.31 - $13.25 $292,985 - $416,977	31,470 Added 302.1%	41,887 $409,000
Q1 2021 May 13, 2021	BUY	$15.01 - $25.74 $156,359 - $268,133	10,417 New	10,417 $188,000

Ticker ANGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,113,300
Description
Angion Biomedica Corp., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapeutics for acute organ injuries and fibrotic diseases. The company's lead product candidate is ANG-3070, an oral tyrosine kinase receptor inhibitor in development as a treatment for fibrotic diseases, primaril...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.